Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pyrosequencing AB

This article was originally published in The Gray Sheet

Executive Summary

Positive clinical trial results for rapid DNA-based prenatal test for Down Syndrome (trisomy 21) lead to expanded R&D agreement with University of Geneva to include diagnostic tests for other trisomies, such as testing at the 18, 13, X and Y chromosomes. Announced May 7, expansion of the 2001 deal comprises genetic analysis and test development using Pyrosequencing technology...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT016555

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel